Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Targeting aberrant replication and DNA repair events for treating breast cancers

Communications Biology(2022)10.1038/s42003-022-03413-wSource: DataRank Database

Targeting aberrant replication and DNA repair events for treating breast cancers is a research paper published in Communications Biology (2022). On theSindex it has a DataRank of 0. It has been cited 8 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access8 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (16 grants)Impact (FWCI 0.63)OA: goldTopics (55)IDs (PubMed, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (25)

Jun Hyoung Park,Panneerdoss Subbarayalu ORCID,Santosh Timilsina ORCID,Kaitlyn Bates,Pooja Yadav ORCID

Live enrichment

PubMed:35610507 OpenAlex:https://openalex.org/W4282929381

U.S. Department of Health & Human Services | NIH | National Cancer Institute

Grant: R01CA179120-01A1

U.S. Department of Health & Human Services | NIH | National Cancer Institute

Grant: R01CA239227-A1

Cancer Prevention and Research Institute of Texas

Grant: RP200110

National Institutes of Health

Grant: 5R01CA234479-04

Energy reprogramming-regulated oncopathways and drug resistance in triple negative breast cancer

National Institutes of Health

Grant: 5P30CA054174-16

SAN ANTONIO CANCER INSTITUTE

National Institutes of Health

Grant: 3P30CA125123-09S3

Baylor College of Medicine Cancer Center

National Institutes of Health

Grant: 5T32CA148724-08

Cancer Biology Training Program

National Institutes of Health

Grant: 1R01CA239227-01A1

FoXM1 inhibition: a novel therapeutic avenue to treat breast cancers

National Institutes of Health

Grant: 5R01CA179120-03

miRNAs:Safe and effective therapeutic adjuvants for treating drug resistant TNBC

NCI NIH HHS

Grant: R01 CA179120

NCI NIH HHS

Grant: R01 CA239227

NCI NIH HHS

Grant: R01 CA205224

NCI NIH HHS

Grant: R01 CA234479

NCI NIH HHS

Grant: P30 CA125123

NCI NIH HHS

Grant: T32 CA148724

NCI NIH HHS

Grant: P30 CA054174

FWCI

0.63

Citation Percentile

0.6%

Citation Trend

2023

2024

2025

goldLicense: cc-by

journalhttps://www.nature.com/articles/s42003-022-03413-w.pdf

publisherhttps://www.nature.com/articles/s42003-022-03413-w.pdf

publisherhttps://www.nature.com/articles/s42003-022-03413-w

journalhttps://doi.org/10.1038/s42003-022-03413-w

repositoryhttps://pubmed.ncbi.nlm.nih.gov/35610507

Fields of Study

Cancer therapeutics and mechanismsDNA Repair MechanismsGenomics, phytochemicals, and oxidative stress0301 basic medicine03 medical and health sciencesAnimalsBreast NeoplasmsDNADNA RepairFemaleHumansMiceReceptors, Estrogen

MeSH Terms

AnimalsBreast NeoplasmsDNADNA RepairFemaleHumansReceptors, EstrogenMice

Keywords

Breast cancerCancer researchMetastasisEstrogen receptorChemotherapyCancerBiologyCancer cellDNA repairMedicineDNAInternal medicineGenetics570Medical SciencesQH301-705.5Biophysics610Breast NeoplasmsBiochemistryArticleMiceReceptorsMedical SpecialtiesMedicine and Health SciencesAnimalsHumansBiology (General)Life SciencesObstetrics and GynecologyEstrogenReceptors, Estrogenand Structural BiologyFemale

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being